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Purpose: Vascular endothelial growth factor (VEGF) plays an important role in homeostasis and diseases of the retinal
pigment epithelium (RPE), choriocapillaris, and, most notably, age-related macular degeneration (AMD). Although much
is known about VEGF regulation in pathologies, little is known about the control of VEGF expression under normal
conditions. VEGF expression has been previously shown to be regulated in coordination with cell differentiation in the
muscle and kidney. We therefore tested the hypothesis that VEGF in the adult RPE would similarly be regulated in
conjunction with differentiation.
Methods: A human retinal pigment epithelium cell line (ARPE-19), a line of immortalized human RPE cells, was used
for all experiments. RPE cells were polarized in culture for 4 weeks on laminin-coated Transwells. Levels of VEGF mRNA
and protein were determined with real-time PCR and enzyme-linked immunosorbent assay, respectively. VEGF-luciferase
reporter constructs were used to identify regions of the VEGF promoter that control VEGF expression in the RPE.
Microphthalmia-associated transcription factor (MITF)-Tfe transcription factors were blocked using either a pan MITF-
Tfe dominant negative or specific small interfering RNA (siRNA).
Results: VEGF mRNA and protein secretion increased over time in the RPE cells cultured on Transwells, with protein
secretion occurring in a polarized fashion primarily toward the basolateral side. Overexpression of a dominant negative
that targets the MITF-Tfe family resulted in a 50% reduction in VEGF expression. The role of the MITF-Tfe family in
VEGF regulation in the RPE was corroborated in studies with the VEGF-luciferase reporter constructs, where deletion of
the distal VEGF promoter region containing putative binding sites for the MITF-Tfe family resulted in a 50% reduction
in VEGF promoter activity. siRNA knockdown of the MITF-Tfe family individually, and in combination, revealed that
downregulation of Tfe3 resulted in reduced VEGF expression.
Conclusions: Our results indicate that Tfe3, in conjunction with other MITF-Tfe members, regulates VEGF expression
in the RPE and are consistent with the hypothesis that VEGF expression in RPE cells is regulated as part of their
differentiation.
Vascular endothelial growth factor (VEGF), also called
VEGF-A, is a member of the cysteine-knot superfamily of
growth factors, which is characterized by the presence of eight
conserved cysteine residues [1,2]. VEGF has been shown to
be  an  important  regulator  of  normal  and  pathological
angiogenesis, the process by which new blood vessels arise
from existing ones [3]. VEGF also plays a role in controlling
vascular permeability [4]. Targeted disruption of VEGF and
its receptors results in early embryonic lethality due to severe
defects in vasculogenesis [5–7]. VEGF expression declines
postnatally,  but  continues  in  specific  cells  in  virtually  all
tissues,  particularly  at  sites  proximal  to  fenestrated
endothelium,  such  as  podocytes  adjacent  to  glomerular
endothelium, and retinal pigment epithelium (RPE) adjacent
to the choriocapillaris [8,9].
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Our laboratory has shown that the RPE is the only source
of VEGF in the back of the eye [10]. RPE-derived VEGF not
only functions in the development [11], maintenance, and
survival  of  the  choriocapillaris  and  the  RPE  but  also
contributes to their pathologies. Aberrant VEGF expression
by the RPE is believed to promote the progression of the
choroidal neovascularization associated with the advanced
form of age-related macular degeneration (AMD). However,
little is known about the molecular regulation of VEGF in the
RPE. Previous studies have identified various factors and
conditions that are capable of influencing VEGF expression,
including hypoxia, mechanical stress, advanced glycation end
products, vasopressor hormones (angiotensin II, vasopressin),
cytokines  (interleukin  1  and  tumor  necrosis  factor),  and
growth factors (TGFβ2, basic fibroblast growth factor, and
platelet-derived  growth  factor)  [12].  Patterns  of  VEGF
expression observed in adults [13] have led to the hypothesis
that cell-specific VEGF expression may be regulated as part
of  the  process  of  cell  differentiation,  and  our  laboratory
demonstrated that VEGF expression by skeletal muscle is
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519regulated in coordination with myogenic differentiation [14].
Motivated by these observations, we aimed the current study
at determining whether VEGF expression is also regulated in
concert with RPE differentiation.
Transcriptional regulation of VEGF occurs through the
core promoter as well as through enhancers or repressors
outside the core promoter domain. VEGF is unique in that its
core  promoter  does  not  contain  typical  transcriptional
initiation recognition sequences, such as a TATA box or a
transcription factor II B recognition element [15]. Researchers
have predicted that the VEGF promoter is controlled by an
SP1 site located 50 base pairs upstream of the transcription
start site [15,16]. Enhancement or repression of VEGF basal
transcription can be controlled by the interaction of specific
transcription factors with the VEGF promoter through, or
independent of, the basal transcriptional machinery.
The  key  transcription  factors  involved  in  RPE
specification  include  Pax6,  Otx2,  and  microphthalmia-
associated transcription factor (MITF). Pax6 is considered the
master regulator of eye development, as the absence of this
factor leads to complete failure of eye development, known
as anophthalmia [17,18]. Pax6 expression ultimately becomes
restricted to the primitive retina, whereas Otx2 and MITF are
localized in the primitive RPE [19,20]. MITF is the key RPE-
specifying transcription factor. Inactivation of MITF in mouse
or quail impairs the development of the presumptive RPE; the
RPE remains non-pigmented and hyperproliferates, becoming
an additional neural retina [21]. Otx2 is thought to act in
conjunction with MITF in a feedback loop to control RPE-
specific gene expression. Otx2 overexpression in retinal cells
leads to pigmentation; the presumptive RPE of mice deficient
in  Otx1/Otx2  is  almost  completely  devoid  of  MITF
expression, lacks pigmentation, and displays an RPE-to-retina
transdifferentiation [20,22]. MITF belongs to the MITF-Tfe
family of transcription factors, which are basic helix–loop–
helix-leucine zipper transcription factors, including MITF,
Tfeb, Tfe3, and Tfec [23]. Therefore, to test the hypothesis
that VEGF regulation is coordinated with cell differentiation,
we evaluated the MITF-Tfe family as candidate modulators
of VEGF expression in the RPE.
METHODS
Cell  culture,  constructs,  and  transient  transfections:
ARPE-19, a human retinal pigment epithelium cell line, were
purchased from ATCC (Mannassa, VA). Cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM)/F12 1:1
supplemented with 10% fetal bovine serum (FBS) and 1%
GlutaMAX, penicillin/streptomycin (GPS), and used through
a maximum of 30 passages. ARPE-19 cells were induced to
polarize by plating at high density (1.7×105 cells) on laminin-
coated  0.4  μm-pore  12-well  Costar  Transwells  (Thermo
Fisher  Scientific,  Cambridge,  MA),  and  maintained  in
DMEM/F12 supplemented with 1% FBS and 1% GPS. Media
were  changed  twice  a  week  for  4  weeks  before  use  in
experiments. Human embryonic kidney 293 (HEK 293) cells
(ATCC) were maintained at subconfluence in DMEM (Gibco;
Rockville, MD) supplemented with 10% FBS and 1% GPS.
Both cell types were incubated at 37 °C in a 5% CO2 incubator
and subcultured using trypsin.
For transfection with dominant negative MITF (kindly
provided by David Fisher, Harvard Medical School, Boston,
MA), which targets the MITF-Tfe transcription factor family,
the ARPE-19 media were changed to 0.1% serum the day
before transfection and maintained in low serum conditions
throughout the experiment to minimize the effect of serum on
VEGF expression. ARPE-19 cells were transfected at 65%–
75%  confluence  using  Lipofectamine  LTX  with  PLUS
reagent (Invitrogen, Carlsbad, CA) in 0.1% FBS DMEM/F12
for  24  h,  and  then  fresh  medium  containing  0.1%  FBS
DMEM/F12 and GPS was added. At 48 h post-transfection,
cells were washed in phosphate buffer solution (PBS; 137 mM
NaCl; 2.7 mM KCl; 4.3 mM Na2HPO4; 1.47 mM KH2PO4, pH
of  7.4;  Sigma-Aldrich,  Saint  Louis,  MO),  and  RNA  was
isolated to analyze gene expression with real-time PCR (qRT–
PCR).
Immunofluorescence:  Occludin  was  localized  in  polarized
ARPE-19 cells. Cells were washed with PBS and fixed in ice-
cold 4% paraformaldehyde for 10 min. After three washes in
PBS, samples were blocked in 0.1% Triton/5% goat serum in
PBS for 2 h at room temperature, and incubated with the
occludin antibody (1:100; Invitrogen) overnight at 4 °C. After
being washed with PBS, the samples were incubated with a
mixture of fluorescein isothiocyanate (FITC)-conjugated goat
antirabbit  fluorescent  secondary  antibody  (1:300;  Jackson
ImmunoResearch Laboratories; West Grove, PA) and 4',6-
diamidino-2-phenylindole  (DAPI;  1:100)  for  1  h  at  room
temperature. The Transwell membranes were cut around the
periphery  of  the  membrane  with  a  razor  blade,  and  then
removed from the well with tweezers. The membranes were
mounted on slides using aqueous mounting media consisting
of 50% glycerol in PBS, and images were taken with an
Axioskop  (Axioskop  MOT  2;  Carl  Zeiss  Meditec,  Inc.,
Dublin, CA).
Small interfering RNA–mediated gene silencing: Knockdown
of MITF, Tfeb, and Tfe3 was achieved with 0.2 μM of ON-
TARGETplus SMARTpools containing four pooled siRNA
duplexes (Dharmacon; Lafayette, CO). A scrambled siRNA
pool (0.2 μM) that lacks identity with known gene targets was
used to control for non-sequence-specific effects. ARPE-19
cells were transfected as above, and three time points (24, 48,
72 h) were tested to determine the optimal post-transfection
time to isolate mRNA. Of the three times, maximal gene
downregulation was noted at 48 h and was therefore selected
as the time point at which mRNA was isolated for analysis
with qRT–PCR.
Luciferase reporter assays: ARPE-19 and HEK 293 cells at
75%–80%  confluence  were  cotransfected  using
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520Lipofectamine  2000  (Invitrogen)  and  FuGENE  6  (Roche
Diagnostics,  Indianapolis,  IN),  respectively,  with  equal
amounts of VEGF firefly luciferase (Fluc)-reporter plasmid,
and Renilla control luciferase (Rluc; Promega, Madison, WI).
The cells were transfected overnight, and fresh medium was
added the following day. Lysates were collected 48 h post-
transfection, and luciferase expression was detected using the
Dual-Luciferase Reporter Assay System (Promega) with a
Turner  Luminometer  (Turner  Designs,  Sunnyvale,  CA),
according to the manufacturer’s instructions. VEGF promoter
activity, as indicated by the Fluc activity, was normalized to
Rluc. The ratio of Fluc to Rluc was then divided by the ratio
of the promoterless luciferase to determine the fold change.
Real-time polymerase chain reaction analysis: Total mRNA
was purified using RNA-Bee solution (Iso-Tex Diagnostic,
Inc.,  Friendswood,  TX)  under  RNase-free  conditions,
according to the manufacturer’s instructions. One microgram
of  RNA  was  reverse-transcribed  using  SuperScript  III
(Invitrogen),  and  cDNA  that  was  diluted  1:20  (50  ng  of
equivalent RNA) was used in each amplification reaction.
Reactions were performed using the SYBR Green Master Mix
and the ABI Prism 9700 Sequence Detection System (Applied
Biosystems, Carlsbad, CA) according to the manufacturer’s
instructions. For primer sequences, see Table 1. The PCR
cycles consisted of an initial denaturation step at 95 °C for 10
min, followed by 40 cycles at 95 °C for 15 s and at 60 °C for
60 s. Each sample was also subjected to melting curve analysis
to  confirm  amplification  specificity.  Samples  were  run  in
duplicate, and each experiment included two non-template
control wells. Samples were normalized to glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), and expressed as the
relative expression using the delta-delta Ct method. Results
are expressed as the mean±standard deviation.
Enzyme-linked  immunosorbent  assay  for  determining
vascular endothelial growth factor levels: Conditioned media
were collected from the apical and basolateral compartments
of ARPE-19 cells that were polarized over the course of 4
weeks.  On  the  day  before  the  conditioned  media  were
collected,  the  media  were  changed  so  that  the  levels  of
secreted VEGF detected would reflect the amount of VEGF
secreted over the course of 24 h. The difference in volume of
the apical (500 μl) versus the basolateral (1.5 ml) compartment
was accounted for in the final calculation. VEGF levels were
determined  with  enzyme-linked  immunosorbent  assay
(ELISA; R&D Systems, Minneapolis, MN), according to the
manufacturer’s protocol.
Statistical  analysis:  Values  are  expressed  as  the  mean
±standard deviation, unless otherwise indicated. Statistical
analysis was performed using an unpaired Student t test (***:
p<0.001, **: p<0.01, *: p<0.05, ns: p>0.05).
RESULTS
VEGF expression in the retinal pigment epithelium increased
during in vitro differentiation: As the first step in elucidating
the  molecular  regulation  of  VEGF  in  the  RPE,  VEGF
expression was analyzed in ARPE-19 cells in an in vitro model
of cell maturation. ARPE-19 cells are an immortalized human
RPE cell line, a useful tool for studying RPE cells in vitro.
ARPE-19 cells recapitulate many characteristics of RPE in
vivo, including the distribution of VEGF isoform expression
[24], the formation of tight junctions [24,25], and increased
transepithelial  resistance  [25].  The  in  vitro  model  of
maturation consists of culturing cells in low serum on laminin-
coated Transwell membranes; ARPE-19 cells mature rapidly
over 4 weeks and continue to mature slowly thereafter [26].
Localization  of  occludin,  a  tight  junction  marker,
demonstrated a cuboidal monolayer, which is associated with
mature ARPE-19 cells (Figure 1). Compared to subconfluent
(70%) or confluent cells on plastic, VEGF in ARPE-19 cells
cultured for 6 weeks on Transwells was upregulated eightfold
(Figure 2). These ARPE-19 cells also displayed increased
expression of Pax6, MITF, and Otx2, the key RPE-specifying
transcription factors (Figure 2). Evaluation of VEGF protein
secretion during the 4 weeks of in vitro maturation revealed
that VEGF secretion correspondingly increased over time,
with  approximately  189  pg/ml  VEGF  detected  at  week  4
compared  to  approximately  62  pg/ml  at  week  1.  VEGF
secretion  was  polarized,  occurring  primarily  (65%–72%)
toward the basolateral side of the RPE (Figure 3).
Distal promoter regions are essential for VEGF expression in
the  retinal  pigment  epithelium:  To  begin  to  examine  the
molecular basis of VEGF expression, constructs containing
various  truncations  of  the  VEGF  promoter  controlling
luciferase were used to determine the regions of the VEGF
promoter that are essential for VEGF expression in the RPE.
TABLE 1. REAL-TIME PCR PRIMER SEQUENCES FOR HUMAN GENES.
Primer name Forward sequence Reverse sequence
GAPDH CAAATTCCATGGCACCGTCA GGAGTGGGTGTCGCTGTTGA
MITF AGCCATGCAGTCCGAAT ACTGCTGCTCTTCAGCG
Tfe3 TCCTGAAGGCCTCTGTGGAT AGGTCCAGAAGGGCATCTGA
Tfeb CGC ATCAAGGAGTTGGGAAT CTCCAGGCGGCGAGAGT
TRP-1 TCTCTGGGCTGTATCTTCTTCC GGCAACACATACCACTTCTCAA
Tyrosinase CATTCTTCTCCTCTTGGCAGA CCGCTATCCCAGTAAGTGGA
VEGF ATCGAGACCCTGGTGGACA CCGCCTCGGCTTGTCACA
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promoter, as well as deletion mutants containing 5.2 kb, 2.1
kb,  and  1.6  kb  of  upstream  VEGF  promoter  (Figure  4).
Analysis of these constructs in ARPE-19 cells revealed a
twofold induction of promoter activity with the full-length 9
kb  VEGF  reporter  construct  over  the  5.2  kb  construct.
Interestingly, similar induction of promoter activity was not
observed in a control cell type (HEK 293), in which maximal
promoter  activity  was  obtained  with  the  2.1  kb  construct
(Figure 5). This observation suggests that RPE may express
transcription factors or enhancers that bind specifically in the
distal region of the VEGF promoter. Sequence analysis of the
VEGF promoter revealed numerous binding sites for several
transcription  factors  required  for  RPE  specification;  most
notably,  the  putative  binding  sites  for  the  MITF-Tfe
transcription factor family were concentrated primarily in the
-5 kb to -9 kb region (Figure 6).
MITF-Tfe family is involved in regulating VEGF in the retinal
pigment epithelium: To determine if the transcription factors
important for RPE specification might also be involved in
regulating VEGF expression, the entire MITF-Tfe family was
inhibited  with  dominant  negative,  or  knocked  down
individually  with  siRNA.  Overexpression  of  a  dominant
negative construct targeting the MITF-Tfe family led to a
significant (50%) reduction in VEGF expression (Figure 7).
The MITF-Tfe family of transcription factors are basic helix–
loop–helix-leucine  zipper  transcription  factors,  including
MITF, Tfeb, Tfe3, and Tfec [23]. These transcription factors
may bind as homodimers or heterodimers to regulate gene
transcription, making the pan MITF-Tfe dominant negative
Figure 1. Occludin localization in polarized human retinal pigment
epithelium (ARPE-19) cells. Occludin (green) and 4',6-diamidino-2-
phenylindole (DAPI; blue) immunolocalization in ARPE-19 cells
that were cultured for 4 weeks on Transwells to induce polarization
reveals  circumferential  junctions  and  demonstrates  a  cuboidal
monolayer. Scale bar is 50 μm.
highly useful in determining the role of this transcription
factor family in modulating gene expression. Notably, the
downregulation of VEGF expression following pan MITF-Tfe
blockade was seen only when transfections were performed
in low serum (0.1%), indicating a role for serum factor in
regulating  VEGF  expression.  The  extent  of  VEGF
downregulation achieved with dominant negative pan MITF-
Tfe closely paralleled that observed with the truncated 5.2 kb
VEGF-luciferase  reporter  construct  that  lacks  the  region
containing the binding sites for the MITF-Tfe family. Taken
together, these findings support the notion that this family is
involved in regulating VEGF expression, either directly or
indirectly.
Figure 2. Vascular endothelial growth factor (VEGF) and retinal
pigment epithelium (RPE) transcription factor expression during
RPE  in  vitro  maturation.  qRT–PCR  analysis  was  performed  on
cDNA isolated from human retinal pigment epithelium (ARPE-19)
cells  that  were  maximally  differentiated  for  6  weeks  and  cells
cultured on plastic that were 70% or 100% confluent. (A) VEGF and
(B)  RPE-transcription  factors  were  upregulated  in  polarized
ARPE-19 cells compared to non-polarized cells cultured on plastic.
The  experiment  was  performed  in  triplicate,  and  the  results  are
expressed as the mean±standard deviation.
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may mediate VEGF regulation, pooled siRNA against MITF
and Tfeb was used. MITF and Tfeb were successfully knocked
down, individually and in combination, yet no effect of their
knockdown on VEGF expression was observed (Figure 8).
Tfe3  knockdown  with  siRNA  led  to  a  20%  reduction  in
VEGF mRNA; however, there was also a three- to fourfold
increase in the known target genes of Tfe3 (tyrosinase-related
protein 1 and tyrosinase; Figure 9). Although the knockdown
of MITF, Tfeb, and Tfe3 was significant at 60%–80%, there
is a possibility that even a low level of expression of these
factors may be sufficient to influence VEGF expression in the
RPE. Alternatively, there could be a redundancy among the
family members so that inhibiting all members of the family
would be necessary to affect VEGF expression. Nevertheless,
these data provide compelling support for the concept that
Figure 3. Retinal pigment epithelium (RPE) secretion of vascular
endothelial  growth  factor  (VEGF)  during  in  vitro  polarization.
Conditioned media were collected from the apical and basolateral
Transwell compartments over the course of 4 weeks and analyzed
for VEGF with enzyme-linked immunosorbent assay (ELISA). A:
Diagram illustrating Transwell system used for culture of human
retinal pigment epithelium (ARPE-19) cells. B: An increase in VEGF
secretion preferentially toward the basolateral side was observed
during  the  4-week  culturing.  The  experiment  was  performed  in
triplicate,  and  the  results  are  expressed  as  the  mean±standard
deviation.
members of this family of transcription factors, particularly
Tfe3, are involved in regulating VEGF expression in the RPE.
DISCUSSION
Analysis  of  ARPE-19  cells  in  vitro  revealed  that  VEGF
mRNA and protein secretion increased during culture for 4 to
6 weeks on Transwells during which time the cells matured
rapidly.  VEGF  secretion  by  ARPE-19  may  continue  to
increase during longer-term in vitro maturation (>1 month),
but  we  also  suspect  that  the  secretion  would  eventually
plateau.  We  found  that  VEGF  protein  secretion  was  also
polarized, occurring primarily toward the basolateral side,
which is consistent with the physiologic evidence that RPE-
derived VEGF supports the underlying choriocapillaris. The
preferential secretion of VEGF toward the basolateral side
corroborated previous findings in primary human RPE cells
[27]. Alternatively, another report suggested that the secretion
may not be polarized, but rather that a higher rate of VEGF
degradation and transcytosis at the apical surface of RPE cells
accounts for the difference [28]. Nevertheless, the fact that the
RPE uses such mechanisms further supports the physiologic
importance  of  controlling  the  amount  of  VEGF  secreted
apically to retain an avascular outer retina. Given the role of
VEGF as a potent angiogenic factor, it has been proposed that
the outer retina is able to remain avascular by complementary
apical  secretion  of  the  anti-angiogenic  factor  pigment
epithelium-derived factor (PEDF) by the RPE. A recent study
reported that PEDF secretion also increases in phenotypically
polarized  human  embryonic  stem  cell-derived  RPE  [29].
Figure 4. Schematic of vascular endothelial growth factor (VEGF)-
luciferase reporter constructs. VEGF-luciferase constructs indicating
the size of upstream VEGF promoter sequence, transcription start
site, and 5′ UTR. VEGF genomic DNA was ligated upstream of a
promoterless luciferase gene in the pGL2-basic plasmid. Deletions
were made by taking advantage of the restriction sites located within
the VEGF promoter and the pGL2 multiple cloning site [16].
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secretion  is  required  to  maintain  eye  homeostasis  during
development, and in the adult.
VEGF expression occurs early during eye development,
at  embryonic  day  9.5  [24]  when  RPE  specification  is
occurring.  This  observation  combined  with  the  increased
VEGF expression during RPE maturation further supports the
notion of coordinated regulation of VEGF expression and cell
differentiation.  VEGF  functions  to  control  tissue
vascularization during development [5,30], and maintains the
vasculature in the adult [31–33]. In light of these critical roles,
Figure  5.  Vascular  endothelial  growth  factor  (VEGF)  promoter
regions involved in regulating VEGF expression in RPE. (A) Human
retinal pigment epithelium cell line (ARPE-19) or (B) HEK 293 cells
were  transfected  with  VEGF-luciferase  constructs  containing
various truncations of the VEGF promoter. There was a twofold
induction of promoter activity with the 9 kb construct over the 5.2
kb construct in (A) ARPE-19 cells. In (B) HEK 293 cells, maximum
promoter  activity  was  achieved  with  the  2.1  kb  construct.  The
experiment was performed in triplicate. A representative experiment
is shown with data expressed as the mean±standard deviation.
it is not surprising that regulation of VEGF in the RPE might
be synchronized with cell differentiation.
To directly test the hypothesis of regulation of VEGF
coordinated with cell differentiation, the role of transcription
factors involved in RPE specification in regulating VEGF
expression was examined. Use of the pan MITF-Tfe dominant
negative provided strong evidence that the MITF-Tfe family
of  transcription  factors  regulates  VEGF  expression  in  the
RPE. This observation was supported by the fact that the distal
region  of  the  VEGF  promoter,  which  contains  putative
binding  sites  for  the  MITF-Tfe  family,  was  essential  for
expression by RPE, but not by HEK 293 cells. The fact that
50%  was  the  maximum  reduction  of  VEGF  expression
achieved using the pan MITF-Tfe dominant negative suggests
that VEGF expression by the RPE is mediated by multiple
mechanisms.  The  reduction  of  VEGF  expression  by  the
dominant negative MITF-Tfe was detected in 0.1% serum,
and the remaining 50% of VEGF expression is likely due, at
Figure 6. Schematic of putative binding sites for transcription factors
in vascular endothelial growth factor (VEGF) promoter. The putative
binding sites for the MITF-Tfe family are primarily concentrated in
the -5 kb to -9 kb region of the VEGF promoter.
Figure 7. Overexpression of dnMITF leads to downregulation of
vascular endothelial growth factor (VEGF) in the retinal pigment
epithelium (RPE). Human retinal pigment epithelium (ARPE-19)
cells were transfected with a dominant negative against the MITF-
Tfe transcription factor family (dnMITF) or an empty vector control
(pBS). RNA was isolated 48 h post-transfection and analyzed with
qRT–PCR.  A  50%  reduction  in  VEGF  mRNA  was  observed  in
samples overexpressing the dnMITF; there was an 80% decrease in
the expression of known targets for the MITF-Tfe family, tyrosinase
(TYR), and tyrosinase-related protein-1 (TRP-1). The experiment
was performed in triplicate. A representative experiment is shown
with data expressed as the mean±standard deviation. *: p<0.05; ***:
p<0.001.
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to induce expression of VEGF family members [34].
Investigation of the relative contribution of individual
MITF-Tfe  family  members  revealed  that  of  the  family
members  tested,  only  knockdown  of  Tfe3  produced  a
reduction in VEGF expression. Interestingly, the reduction of
VEGF expression occurred without a decrease in Tfe3 known
targets. This observation is likely because alternative splicing
of Tfe3 gives rise to two isoforms: Tfe3L and Tfe3S. Tfe3S,
which lacks the N-terminal acidic activation domain present
in Tfe3L, has a fourfold lower activation potential than Tfe3L,
and has been reported to have a dominant negative effect
against Tfe3L [35]. Therefore, knockdown of Tfe3S would
eliminate its dominant negative effect and may well account
for  the  increased  expression  of  the  downstream  targets,
tyrosinase-related  protein  1  and  tyrosinase.  Given  that
depletion of the entire MITF-Tfe family was necessary to
affect  a  50%  reduction  in  VEGF  expression  indicates
functional redundancy among the members of the MITF-Tfe
family.
Figure 8. Knockdown of MITF and/or Tfeb does not affect vascular
endothelial  growth  factor  (VEGF)  expression.  Human  retinal
pigment  epithelium  (ARPE-19)  cells  were  transfected  with  an
siControl or a SMARTpool targeting MITF and/or Tfeb. Depletion
of (A) MITF and/or (B) Tfeb did not reduce VEGF expression. The
experiment was performed in triplicate. A representative experiment
is shown with data expressed as the mean±standard deviation. *:
p<0.05; ***: p<0.001; ns: p>0.05.
The pattern and timing of VEGF expression in vivo are
consistent with a role for the MITF-Tfe family in modulating
VEGF expression by the RPE. MITF expression commences
in the optic vesicle at E9.0, and by E9.5 MITF is localized
primarily in the proximal optic vesicle, with less expression
in  the  region  of  the  optic  vesicle  adjacent  to  the  surface
ectoderm [21]. VEGF expression in the developing retina
arises between E9.0 and E9.5, and at E9.5, VEGF is primarily
detected in the proximal optic vesicle [24]. At E9.5, MITF and
VEGF have similar patterns of expression. In addition, the
Tfeb knockout mouse is embryonic lethal, with mice dying
between  E9.5  and  E10.5  due  to  placental  vascularization
defects [36]. Interestingly, labyrinthine cells in the mutant
Tfeb placenta failed to express VEGF, suggesting that Tfeb
regulates  VEGF  in  the  placenta.  Taken  together  with  our
findings, it appears that Tfe3, in conjunction with other MITF-
Tfe members, may regulate VEGF expression in the RPE.
Figure  9.  Tfe3  knockdown  leads  to  a  reduction  in  vascular
endothelial  growth  factor  (VEGF)  expression.  Human  retinal
pigment  epithelium  (ARPE-19)  cells  were  transfected  with  an
siControl or a SMARTpool targeting Tfe3. A: A 20% reduction in
VEGF  expression  and  (B)  a  three-  to  fourfold  increase  in  Tfe3
downstream targets TRP-1 and tyrosinase were observed with Tfe3
depletion.  The  experiment  was  performed  in  triplicate.  A
representative experiment is shown with data expressed as the mean
±standard deviation. *: p<0.05; **: p<0.01.
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525There  is  increasing  evidence  for  a  link  between  the
development and progression of AMD and the status of the
RPE. A recent report illustrated that oxidative stress can lead
to  RPE  dedifferentiation  and  hypertrophy,  which  leads  to
decreased expression of several essential genes involved in
RPE  functions,  including  phagocytosis  (MER  tyrosine
kinase),  and  the  conversion  of  all-trans-retinal  to  11-cis-
retinal  (RPE65)  [37].  Interestingly,  of  the  six  RPE-
characteristic  markers  tested  in  that  study,  only  MITF
increased in expression. The dysfunctional RPE may lead to
photoreceptor cell death, while the elevated MITF could cause
increased VEGF expression, promoting progression to the
advanced form of AMD.
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